EXECUTIVE ENGAGEMENTS
POOL
489
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
98
Interactions with Platform & by Email
PARTICIPANTS
22
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPANIES
44
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
123
PAGES
193
EDITION
8
PRICE
USD 4950
CODE
MCP16589
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Microbiome Sequencing Services estimated at US$931.8 Million in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 17.8% over the analysis period 2020-2027. Synthesis, one of the segments analyzed in the report, is projected to record a 16.6% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ligation segment is readjusted to a revised 14.6% CAGR for the next 7-year period.
The Microbiome Sequencing Services market in the U.S. is estimated at US$275.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$507.9 Million by the year 2027 trailing a CAGR of 17.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.6% and 15.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.
In the global Pyrosequencing segment, USA, Canada, Japan, China and Europe will drive the 21.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$110.9 Million in the year 2020 will reach a projected size of US$443.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$356.6 Million by the year 2027.
SELECT PLAYERS
Clinical-Microbiomics A/S; Diversigen, Inc.; GATC Biotech AG; Second Genome
SEGMENTS
» End-Use (Pharmaceutical, Academic & Research Institutes, Biotech) » Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Microbiome Sequencing Services – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Microbiome Sequencing Services Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| JAPAN |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| CHINA |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| EUROPE |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| FRANCE |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| GERMANY |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| UNITED KINGDOM |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| ASIA-PACIFIC |
| Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com